Hormone Therapy in Treating Patients With Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer, Sexual Dysfunction and Infertility

In brief

RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide and finasteride may fight prostate cancer by reducing the production of male hormones. PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating prostate cancer patients with high PSA levels who were previously treated with radiation therapy or radical prostatectomy.

Key facts

Study ID
NCT00003323
Run by
Alliance for Clinical Trials in Oncology
People needed
101
Starts
1998-05-01
Expected to finish
2010-03-01
Last updated by the study team
2016-07-04

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.